Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

232.68
+8.153.63%
Post-market: 232.60-0.0800-0.03%19:30 EDT
Volume:959.45K
Turnover:222.02M
Market Cap:31.05B
PE:41.41
High:232.94
Open:224.74
Low:222.71
Close:224.53
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.67
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:22.93
PE(LYR):99.86

Loading ...

Alnylam Pharmaceuticals Initiated at Outperform by BMO Capital

Dow Jones
·
Aug 19

Alnylam Pharma (ALNY) Gets a Hold from Wells Fargo

TIPRANKS
·
Aug 14

U.S. Research Roundup-Cisco, Fox Corp, Target

Reuters
·
Aug 14

Alnylam Pharma (ALNY) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Aug 13

Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)?

Simply Wall St.
·
Aug 12

Movement Alert|Alnylam Pharmaceuticals Falls 5.04% in Regular Trading, Continued Pressure After Q2 Guidance Cut

Market Focus
·
Aug 07

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Tenaya Net Loss Widens to $43.39 Million in Q2 FY26; R&D Expenses Slip to $16.6 Million

Reuters
·
Aug 06

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05

Reuters
·
Aug 05

H.C. Wainwright Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 04

Alnylam Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 04

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485

THOMSON REUTERS
·
Aug 04

U.S. Research Roundup-Cloudflare, Replimune, Walmart

Reuters
·
Aug 04

Movement Alert|Alnylam Pharmaceuticals Rises 5.47% in Regular Trading, Multiple Institutions Call Prior 28% Selloff Overdone

Market Focus
·
Aug 03

Alnylam Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Aug 03

Alnylam price target lowered to $450 from $527 at Barclays

TIPRANKS
·
Aug 03

Alnylam Pharmaceuticals Share Price Weakness Looks 'Overdone' Despite Softer Quarter, RBC Says

MT Newswires Live
·
Jul 31

RBC Cuts Price Target on Alnylam Pharmaceuticals to $350 From $445, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (KPTI), Baxter International (BAX) and Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 31

Alnylam price target lowered to $300 from $400 at Morgan Stanley

TIPRANKS
·
Jul 31